id | C00008126 |
---|---|
Name | 7-Hydroxyflavanone |
CAS RN | 6515-36-2 |
Standard InChI | InChI=1S/C15H12O3/c16-11-6-7-12-13(17)9-14(18-15(12)8-11)10-4-2-1-3-5-10/h1-8,14,16H,9H2 |
Standard InChI (Main Layer) | InChI=1S/C15H12O3/c16-11-6-7-12-13(17)9-14(18-15(12)8-11)10-4-2-1-3-5-10/h1-8,14,16H,9H2 |
Phytochemical cluster | No. 14 |
---|---|
KCF-S cluster | No. 25 |
By standard InChI | CHEMBL97542 |
---|---|
By standard InChI Main Layer | CHEMBL97542 CHEMBL402744 |
By LinkDB | C14290 |
---|
By CAS RN | C059353 |
---|
class name | count |
---|---|
rosids | 5 |
asterids | 2 |
Magnoliophyta | 1 |
family name | count |
---|---|
Fabaceae | 5 |
Ericaceae | 1 |
Myristicaceae | 1 |
Asteraceae | 1 |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P04637 | Cellular tumor antigen p53 | Transcription Factor | CHEMBL97542 |
CHEMBL1738132
(1)
|
7 / 44 |
P05091 | Aldehyde dehydrogenase, mitochondrial | Oxidoreductase | CHEMBL97542 |
CHEMBL641142
(1)
|
1 / 1 |
P38398 | Breast cancer type 1 susceptibility protein | Enzyme | CHEMBL97542 |
CHEMBL2114807
(1)
|
4 / 2 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | CHEMBL97542 |
CHEMBL2114788
(1)
|
0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | CHEMBL97542 |
CHEMBL1052489
(1)
CHEMBL1052500
(1)
|
0 / 1 |
P11511 | Cytochrome P450 19A1 | Cytochrome P450 19A1 | CHEMBL97542 |
CHEMBL649354
(1)
CHEMBL932215
(1)
CHEMBL932216 (1) |
2 / 2 |
P10275 | Androgen receptor | NR3C4 | CHEMBL97542 |
CHEMBL1052499
(1)
|
3 / 4 |
P27338 | Amine oxidase [flavin-containing] B | Oxidoreductase | CHEMBL97542 |
CHEMBL731145
(1)
|
0 / 0 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | CHEMBL97542 |
CHEMBL731145
(1)
|
1 / 1 |
compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
---|---|---|---|---|---|---|---|
C059353 | 1588 |
CYP19A1
ARO ARO1 CPV1 CYAR CYP19 CYPXIX P-450AROM |
cytochrome P450, family 19, subfamily A, polypeptide 1 (EC:1.14.14.1) | 7-hydroxyflavanone results in decreased activity of CYP19A1 protein |
decreases activity
|
protein |
15319488
|
OMIM | preferred title | UniProt |
---|---|---|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#610251 | Alcohol sensitivity, acute |
P05091
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#613546 | Aromatase deficiency |
P11511
|
#139300 | Aromatase excess syndrome; aexs |
P11511
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#114480 | Breast cancer |
P38398
|
#604370 | Breast-ovarian cancer, familial, susceptibility to, 1; brovca1 |
P38398
|
#300615 | Brunner syndrome |
P21397
|
#133239 | Esophageal cancer |
P04637
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#211980 | Lung cancer |
P04637
|
#167000 | Ovarian cancer |
P38398
|
#614320 | Pancreatic cancer, susceptibility to, 4; pnca4 |
P38398
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
KEGG | disease name | UniProt |
---|---|---|
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
P11511 (related) |
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00016 | Oral cancer |
P04637
(related)
P04637 (marker) |
H00017 | Esophageal cancer |
P04637
(related)
P04637 (marker) |
H00018 | Gastric cancer |
P04637
(related)
|
H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00022 | Bladder cancer |
P04637
(related)
|
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) |
H00026 | Endometrial Cancer |
P04637
(related)
|
H00027 | Ovarian cancer |
P04637
(related)
P38398 (related) |
H00028 | Choriocarcinoma |
P04637
(related)
|
H00029 | Vulvar cancer |
P04637
(related)
|
H00031 | Breast cancer |
P04637
(related)
P38398 (related) |
H00032 | Thyroid cancer |
P04637
(related)
|
H00033 | Adrenal carcinoma |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
|
H00038 | Malignant melanoma |
P04637
(related)
|
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00042 | Glioma |
P04637
(related)
P04637 (marker) |
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00046 | Cholangiocarcinoma |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00055 | Laryngeal cancer |
P04637
(related)
P04637 (marker) |
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H01071 | Acute alcohol sensitivity |
P05091
(related)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00794 | Aromatase excess syndrome |
P11511
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|